202 related articles for article (PubMed ID: 36459898)
21. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
[TBL] [Abstract][Full Text] [Related]
22. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study.
Huang W; Kanehira K; Drew S; Pier T
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):12-7. PubMed ID: 18769342
[TBL] [Abstract][Full Text] [Related]
23. Expression analysis of Wnt-5a in renal epithelial neoplasms: distinguishing renal oncocytoma from a wide spectrum of renal cell carcinomas.
Rao Q; Liu XH; Zhou HB; Ma HH; Lu ZF; Zhou XJ
Tumori; 2010; 96(2):304-9. PubMed ID: 20572590
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of multidetector computed tomography to differentiate between renal cell carcinoma and oncocytoma. A model validation.
Paño B; Soler A; Goldman DA; Salvador R; Buñesch L; Sebastià C; Nicolau C
Br J Radiol; 2020 Nov; 93(1115):20200064. PubMed ID: 32706993
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
Kuroda N; Kanomata N; Yamaguchi T; Imamura Y; Ohe C; Sakaida N; Hes O; Michal M; Shuin T; Lee GH
Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Utility of Caveolin-1 and MOC-31 in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
Lee HW; Lee EH; Lee CH; Chang HK; Rha SH
Korean J Urol; 2011 Feb; 52(2):96-103. PubMed ID: 21379425
[TBL] [Abstract][Full Text] [Related]
27. CT-based radiomics for differentiating renal tumours: a systematic review.
Bhandari A; Ibrahim M; Sharma C; Liong R; Gustafson S; Prior M
Abdom Radiol (NY); 2021 May; 46(5):2052-2063. PubMed ID: 33136182
[TBL] [Abstract][Full Text] [Related]
28. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
[TBL] [Abstract][Full Text] [Related]
30. Textural differences between renal cell carcinoma subtypes: Machine learning-based quantitative computed tomography texture analysis with independent external validation.
Kocak B; Yardimci AH; Bektas CT; Turkcanoglu MH; Erdim C; Yucetas U; Koca SB; Kilickesmez O
Eur J Radiol; 2018 Oct; 107():149-157. PubMed ID: 30292260
[TBL] [Abstract][Full Text] [Related]
31. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.
Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057
[TBL] [Abstract][Full Text] [Related]
32. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
33. Immunostaining characteristics of irisin in benign and malignant renal cancers.
Kuloğlu T; Artaş G; Yardim M; Sahin I; Aydin Y; Beyoğlu N; Özercan IH; Yalcin MH; Ugur K; Aydin S
Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263
[TBL] [Abstract][Full Text] [Related]
34. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
35. Different DNA ploidy patterns for the differentiation of common subtypes of renal tumors.
Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Genin C; Tostain J
Cell Oncol; 2005; 27(1):51-6. PubMed ID: 15750207
[TBL] [Abstract][Full Text] [Related]
36. Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.
Zhong Y; Wang H; Shen Y; Guo A; Wang J; Kang S; Ma L; Pan J; Ye H
Eur Radiol; 2017 Dec; 27(12):4913-4922. PubMed ID: 28631081
[TBL] [Abstract][Full Text] [Related]
37. Circularity Index on Contrast-Enhanced Computed Tomography Helps Distinguish Fat-Poor Angiomyolipoma from Renal Cell Carcinoma: Retrospective Analyses of Histologically Proven 257 Small Renal Tumors Less Than 4 cm.
Kang HS; Park JJ
Korean J Radiol; 2021 May; 22(5):735-741. PubMed ID: 33660463
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of rapid kV-switching dual energy CT in renal tumor characterization.
Çamlıdağ İ; Nural MS; Danacı M; Özden E
Abdom Radiol (NY); 2019 May; 44(5):1841-1849. PubMed ID: 30637472
[TBL] [Abstract][Full Text] [Related]
39. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
40. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
